tm logo
TAZOVID
Live/Registered
REGISTERED

on 08 Oct 2024

Last Applicant/ Owned by

Zherong County, Ningde 355300 Fujian

CN

Serial Number

79372184 filed on 13th Apr 2023

Registration Number

7525664 registered on 08th Oct 2024

in the Principal Register

Correspondent Address

Michelle P. Ciotola

Michelle P. Ciotola Cantor Colburn LLP

22nd Floor

Hartford, CT 06103

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

TAZOVID

Medicines for human purposes for the treatment of insomnia, amnesia, asthenia, neurasthenia, chronic chest diseases, chronic tracheitis and bronchitis, coronary thrombosis, fever, influenza, vertigo, hyperlipidemia, adiposity, obesity and COVID-19; Pharmaceutical preparations for the treatment of insomnia, amnesia, asthenia, neurasthenia, chronic chest diseases, chronic tracheitis and bronchitis, Read More

Classification Information


Class [005]
Pharmaceutical Products


Medicines for human purposes for the treatment of insomnia, amnesia, asthenia, neurasthenia, chronic chest diseases, chronic tracheitis and bronchitis, coronary thrombosis, fever, influenza, vertigo, hyperlipidemia, adiposity, obesity and COVID-19; Pharmaceutical preparations for the treatment of insomnia, amnesia, asthenia, neurasthenia, chronic chest diseases, chronic tracheitis and bronchitis, coronary thrombosis, fever, influenza, vertigo, hyperlipidemia, adiposity, obesity and COVID-19; Capsules being medicines for the treatment of insomnia, amnesia, asthenia, neurasthenia, chronic chest diseases, chronic tracheitis and bronchitis, coronary thrombosis, fever, influenza, vertigo, hyperlipidemia, adiposity, obesity and COVID-19; Drugs for medical purposes for the treatment of insomnia, amnesia, asthenia, neurasthenia, chronic chest diseases, chronic tracheitis and bronchitis, coronary thrombosis, fever, influenza, vertigo, hyperlipidemia, adiposity, obesity and COVID-19; vaccines; Ointments for pharmaceutical purposes for the treatment of skin conditions; Medicines in the form of tablets for the treatment of insomnia, amnesia, asthenia, neurasthenia, chronic chest diseases, chronic tracheitis and bronchitis, coronary thrombosis, fever, influenza, vertigo, hyperlipidemia, adiposity, obesity and COVID-19; biocides; Dietetic preparations adapted for medical purposes; Depuratives for the body; Medicines for veterinary purposes for the treatment of COVID-19; dental lacquer


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79372184

Mark Type

No Service/Collective Mark

Attorney Docket Number

No BYL0191TUS

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
08th Oct 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
08th Oct 2024REGISTERED-PRINCIPAL REGISTER
23rd Jul 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23rd Jul 2024PUBLISHED FOR OPPOSITION
03rd Jul 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14th Jun 2024EXAMINER'S AMENDMENT ENTERED
14th Jun 2024APPROVED FOR PUB - PRINCIPAL REGISTER
14th Jun 2024EXAMINERS AMENDMENT -WRITTEN
14th Jun 2024EXAMINERS AMENDMENT E-MAILED
14th Jun 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED